Glenn H Nussdorf bought $1.1M of ORGO
director, owner at Organogenesis Holdings Inc.. 358,495 shares at an average of $3.06, traded May 14, 2025, filed Nov 3, 2025.
Score components
- +15RoleDirector
- +25Trade size$1.1M at market
- +8Relative to holdingsFirst purchase: no shares before this trade
- +8Price context52% below the 52-week high
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +24.8%, 3m +5.8%, 6m -36.0%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0002064832-25-000013, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| May 14, 2025 | POpen-market purchase Class A Common Stockindirect: By Glenn Nussdorf 10 Year Follow On Trust Dated 11-1-1998 | +251,001 | $3.09 | $775k | 251,001 | Nov 3, 2025 |
| May 15, 2025 | POpen-market purchase Class A Common Stockindirect: By Glenn Nussdorf 10 Year Follow On Trust Dated 11-1-1998 | +107,494 | $2.99 | $321k | 358,495 | Nov 3, 2025 |
| Jun 9, 2025 | SOpen-market sale Class A Common Stockindirect: By Glenn Nussdorf 10 Year Follow On Trust Dated 11-1-1998 | -4,156 | $3.50 | $15k | 354,339 | Nov 3, 2025 |
| Jun 10, 2025 | SOpen-market sale Class A Common Stockindirect: By Glenn Nussdorf 10 Year Follow On Trust Dated 11-1-1998 | -18,620 | $3.56 | $66k | 335,719 | Nov 3, 2025 |
Related signals
Other insiders at Organogenesis Holdings Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 46Moderate | Organogenesis Holdings Inc. | Michael Joseph Driscoll director | $27k 10,000 shares | +5% | |
| 41Moderate | Organogenesis Holdings Inc. | Arthur S Leibowitz director | $13k 5,000 shares | +2% | |
| 40Moderate | ORGOsell Organogenesis Holdings Inc. | Glenn H Nussdorf director | $1.0M 200,000 shares | -7% | |
| 40Moderate | ORGOsell Organogenesis Holdings Inc. | Glenn H Nussdorf director, owner | $1.6M 300,000 shares | -10% | |
| 24Weak | ORGOsell Organogenesis Holdings Inc. | Glenn H Nussdorf director, owner | $81k 22,776 shares | -6% | |
| 50Moderate | ORGObuy Organogenesis Holdings Inc. | Lori Freedman Chief Admin. and Legal Officer | $725k 252,264 shares | +42% | |
| 31Weak | ORGOsell Organogenesis Holdings Inc. | Michael Joseph Driscoll director | $128k 25,000 shares | -13% | |
| 37Weak | ORGOsell Organogenesis Holdings Inc. | Gary S. Gillheeney President and CEO | $206k 61,200 shares | -2% | |
| 49Moderate | ORGOsell Organogenesis Holdings Inc. | Gary S. Gillheeney President and CEO | $940k 259,332 shares | -8% | |
| 22Weak | ORGOsell Organogenesis Holdings Inc. | Gary S. Gillheeney President and CEO | $212k 59,468 shares | -2% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.